Brenda Libby Coleman

Array ( [id] => 5733527 [patent_doc_number] => 20060258644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Pyrrolobenzodiazepines and heteroaryl, aryl and cycloalkylamino ketone derivatives as follicle stimulating hormone receptor (FSH-R) antagonists' [patent_app_type] => utility [patent_app_number] => 11/432177 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17321 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258644.pdf [firstpage_image] =>[orig_patent_app_number] => 11432177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322638 [patent_doc_number] => 07517871 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders' [patent_app_type] => utility [patent_app_number] => 11/417859 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32474 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517871.pdf [firstpage_image] =>[orig_patent_app_number] => 11417859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 352693 [patent_doc_number] => 07491715 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-17 [patent_title] => 'Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders' [patent_app_type] => utility [patent_app_number] => 11/417441 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32412 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/491/07491715.pdf [firstpage_image] =>[orig_patent_app_number] => 11417441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5683538 [patent_doc_number] => 20060199808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof' [patent_app_type] => utility [patent_app_number] => 11/417071 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16483 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199808.pdf [firstpage_image] =>[orig_patent_app_number] => 11417071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5683543 [patent_doc_number] => 20060199813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Tetrahydroquinoline analogues as muscarinic agonists' [patent_app_type] => utility [patent_app_number] => 11/417865 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65465 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199813.pdf [firstpage_image] =>[orig_patent_app_number] => 11417865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786599 [patent_doc_number] => 20060205714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof' [patent_app_type] => utility [patent_app_number] => 11/416673 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16483 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205714.pdf [firstpage_image] =>[orig_patent_app_number] => 11416673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 256426 [patent_doc_number] => 07576100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-18 [patent_title] => 'Muscarinic agonists' [patent_app_type] => utility [patent_app_number] => 11/417867 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65468 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/576/07576100.pdf [firstpage_image] =>[orig_patent_app_number] => 11417867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4442413 [patent_doc_number] => 07928101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof' [patent_app_type] => utility [patent_app_number] => 11/414499 [patent_app_country] => US [patent_app_date] => 2006-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12446 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928101.pdf [firstpage_image] =>[orig_patent_app_number] => 11414499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705739 [patent_doc_number] => 20060194787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Protease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/410558 [patent_app_country] => US [patent_app_date] => 2006-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41569 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194787.pdf [firstpage_image] =>[orig_patent_app_number] => 11410558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272486 [patent_doc_number] => 20090076262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'PROCESS FOR PREPARING QUETIAPINE AND QUETIAPINE FUMARATE' [patent_app_type] => utility [patent_app_number] => 11/911898 [patent_app_country] => US [patent_app_date] => 2006-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7052 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076262.pdf [firstpage_image] =>[orig_patent_app_number] => 11911898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480945 [patent_doc_number] => 20090203902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Asymmetric catalytic reduction of oxcarbazepine' [patent_app_type] => utility [patent_app_number] => 11/997104 [patent_app_country] => US [patent_app_date] => 2006-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7543 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203902.pdf [firstpage_image] =>[orig_patent_app_number] => 11997104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5924240 [patent_doc_number] => 20060241100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Acylaminobicyclic heteroaromatic compounds and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/409458 [patent_app_country] => US [patent_app_date] => 2006-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23004 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241100.pdf [firstpage_image] =>[orig_patent_app_number] => 11409458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 580832 [patent_doc_number] => 07452907 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method' [patent_app_type] => utility [patent_app_number] => 11/406799 [patent_app_country] => US [patent_app_date] => 2006-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18415 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452907.pdf [firstpage_image] =>[orig_patent_app_number] => 11406799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5890443 [patent_doc_number] => 20060276641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Process for preparing quetiapine fumarate' [patent_app_type] => utility [patent_app_number] => 11/404285 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7592 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276641.pdf [firstpage_image] =>[orig_patent_app_number] => 11404285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 910381 [patent_doc_number] => 07329653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-12 [patent_title] => 'Cyclohexylphenyl vasopressin agonists' [patent_app_type] => utility [patent_app_number] => 11/403072 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6342 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/329/07329653.pdf [firstpage_image] =>[orig_patent_app_number] => 11403072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 928620 [patent_doc_number] => 07314930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-01 [patent_title] => 'Process for preparing dibenzothiazepine derivatives' [patent_app_type] => utility [patent_app_number] => 11/392577 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8072 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/314/07314930.pdf [firstpage_image] =>[orig_patent_app_number] => 11392577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575995 [patent_doc_number] => 20090143357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHK1' [patent_app_type] => utility [patent_app_number] => 11/908416 [patent_app_country] => US [patent_app_date] => 2006-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26215 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143357.pdf [firstpage_image] =>[orig_patent_app_number] => 11908416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9250538 [patent_doc_number] => 08614316 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-24 [patent_title] => 'Optically active quaternary ammonium salt having axial asymmetry and process for producing α-amino acid and derivative thereof with the same' [patent_app_type] => utility [patent_app_number] => 11/910364 [patent_app_country] => US [patent_app_date] => 2006-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65513 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596091 [patent_doc_number] => 07981879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'HIV integrase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/887305 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45243 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981879.pdf [firstpage_image] =>[orig_patent_app_number] => 11887305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639798 [patent_doc_number] => 20100174066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'PROCESS FOR PREPARING CRYSTALLINE FORM I OF OLANZAPINE' [patent_app_type] => utility [patent_app_number] => 11/909275 [patent_app_country] => US [patent_app_date] => 2006-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4167 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0174/20100174066.pdf [firstpage_image] =>[orig_patent_app_number] => 11909275 [rel_patent_id] =>[rel_patent_doc_number] =>)